Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, a minor technical update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:31:03.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a Texas location under Locations and updated the revision to v3.3.3. Removed footer/related entries for HHS Vulnerability Disclosure, MedlinePlus Genetics, and Texas Locations.
    Difference
    0.4%
    Check dated 2025-12-30T16:32:41.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays related-topic links for Prostate cancer and MedlinePlus Genetics, enhancing access to disease- and genetics-related information.
    Difference
    0.2%
    Check dated 2025-12-16T03:31:08.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed related topics 'Prostate cancer' and 'MedlinePlus Genetics' and added the label 'Revision: v3.3.2'. This is a minor UI/content update and does not affect the study details.
    Difference
    0.2%
    Check dated 2025-11-24T21:23:00.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added Prostate cancer tag and related topic MedlinePlus Genetics to the page. Removed the government funding status notice.
    Difference
    0.6%
    Check dated 2025-11-17T19:15:51.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Removed the topic label 'Prostate cancer' and the related topic 'MedlinePlus Genetics' from the page. This could affect topic-based navigation and the visibility of prostate cancer-related information on the study page.
    Difference
    0.2%
    Check dated 2025-11-10T17:07:06.000Z thumbnail image

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.